Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Clodronic acid best for metastatic bone disease in Brazil

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Clodronic acid best for metastatic bone disease in Brazil. Pharmacoecon. Outcomes News 642, 14 (2011). https://doi.org/10.2165/00151234-201106420-00025

    Download citation

    Keywords

    • Economic Evaluation
    • Outcome News
    • Direct Cost
    • Bone Disease
    • Zoledronic Acid